NRx Pharmaceuticals (NRXP) Appoints Stephen Willard as CEO and Director

Go back to NRx Pharmaceuticals (NRXP) Appoints Stephen Willard as CEO and Director
(NASDAQ: NRXP) Delayed: 3.51 +0.18 (5.41%)
Previous Close $3.33    52 Week High
Open $3.36    52 Week Low
Day High $3.55    P/E N/A 
Day Low $3.33    EPS
Volume 809,121